Skip to main content
Top

Biotherapy

Issue 1/1998

Content (7 Articles)

Passive immunotherapy in advanced HIV infection and therapeutic plasmapheresis in asymptomatic HIV-positive individuals: a four-year clinical experience

Gary Blick, William F. Scott, Steven W Crook, Shari Buchanan, Trish Garton, Una Hopkins, Anne Marie Vadaboncoeur, James Doolittle, Iain A. Bulcraig, Paola Greiger-Zanlungo, Abraham Karpas

Use of recombinant interferon gamma in pediatric patients with advanced juvenile chronic arthritis

C. Coto, G. Varela, V. Hernández, M. del Rosario, P. López-Saura

Effectiveness of weekly subcutaneous recombinant human erythropoietin administration for chemotherapy-induced anemia

Mamoru Tsukuda, Seiichiro Yuyama, Hidehiro Kohno, Keiko Itoh, Toshiyuki Kokatsu, Satoshi Kawai

High levels of soluble IFN γ receptor α chain in the plasma of rheumatoid arthritis patients

Iraldo Bello, Anaiza Perez, Ana Maria Torres, Maria Victoria Hernández, Pedro López Saura

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine